Craig is an associate in the New York office of Wilson Sonsini Goodrich & Rosati (WSGR) and joined the firm in 2008 as a patent agent. Dr. Kenesky applies his background in synthetic organic, medicinal, peptide, bioorganic, and computational chemistry to the prosecution of domestic and foreign patent applications, as well as due diligence, freedom to operate, portfolio development strategy, opinions, and IP counseling. Craig represents clients in numerous technology-focused industries, including the chemical, pharmaceutical, biotechnology, nanotechnology, diagnostic, neutriceutical, healthcare, process and manufacturing, energy, clean technology, biofuel, genomics, software, information technology, bioinformatics, scientific instrument, personalized medicine, and medical device sectors. He performs pre-transaction due diligence on behalf of both technology companies and venture capital groups, and he develops non-infringement and invalidity strategies for generic pharmaceutical companies.
Formerly he held a fellowship at Columbia University, where he developed artificial enzymes and synthetic organic nanowires. In addition, Craig’s doctoral research at the University of Pennsylvania focused on the total synthesis of architecturally complex anti-cancer natural products, inhibitors of HIV-1 protease, carbohydrate drugs, peptide-like biomaterials, and the computational and biochemical investigation of tubulin-drug interactions leading to cancer cell death.